USD10
SUPN Shares
About SupernusSupernus Inc is a diversified biopharmaceutical company focused on developing and commercializing treatments for patients living with central nervous system (CNS) diseases. The company's commercial portfolio includes approved treatments designed to support individuals navigating opioid use disorder (OUD), attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's disease (PD) for those receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea.

USD10
SUPN Shares
About SupernusSupernus Inc is a diversified biopharmaceutical company focused on developing and commercializing treatments for patients living with central nervous system (CNS) diseases. The company's commercial portfolio includes approved treatments designed to support individuals navigating opioid use disorder (OUD), attention-deficit hyperactivity disorder (ADHD), dyskinesia in Parkinson's disease (PD) for those receiving levodopa-based therapy, hypomobility in PD, postpartum depression (PPD), epilepsy, migraine, cervical dystonia, and chronic sialorrhea.

Stats

TRADING WINDOW

Closed

OPENS AT

Nov 5 at 2:30 PM UTC

MARKET CAP

$1.63B

OPEN PRICE

Not enough data

LOW (1Y)

$27.97

HIGH (1Y)

$59.68

LOW (24H)

$26.74

HIGH (24H)

$28.99

VOLUME (24H)

$1.00

100%

Price history

Time
Price
Change
Today
Not enough data
Not enough data
1 Day
$28.00
0.21%
1 Week
$41.72
32.74%
1 Month
$42.68
34.25%
1 Year
$47.27
40.63%
Past performance is not a reliable indicator of future results.

Discover more

Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.